Immunotherapy for cancer in people living with HIV-Reference-Cited by-同舟云学术

Immunotherapy for cancer in people living with HIV

Published:2019-09-01 Issue:11 Volume:33 Page:F13-F19
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Spano Jean-Philippe,Veyri Marianne,Gobert Aurélien,Guihot Amélie,Perré Philippe,Kerjouan Mallorie,Brosseau Solenn,Cloarec Nicolas,Montaudié Henri,Helissey Carole,Flament Thomas,Gounant Valérie,Lavolé Armelle,Poizot-Martin Isabelle,Katlama Christine

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference38 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

2. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011

3. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma;Hamid;N Engl J Med,2013

4. Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial;Ribas;Lancet Oncol,2015

5. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pembrolizumab in an HIV-infected patient with glioblastoma;Immunotherapy;2024-06-18

2. The Missed Opportunity: HIV, Hepatitis C Virus (HCV), and Hepatitis B Virus (HBV) Positive Patients in Neoadjuvant and Perioperative Immunotherapy Clinical Trials for Lung Cancer;Cureus;2023-12-29

3. Immune checkpoint inhibitors as potential therapy for reverting T-cell exhaustion and reverting HIV latency in people living with HIV;Frontiers in Immunology;2023-12-07

4. Examining Exclusion Criteria in Advanced Prostate Cancer Clinical Trials: An Assessment of recommendations From the American Society Of Clinical Oncology and Friends of Cancer Research;Clinical Genitourinary Cancer;2023-12

5. Microphysiological model reveals the promise of memory-like natural killer cell immunotherapy for HIV± cancer;Nature Communications;2023-10-21